Inventor · disambiguated record
Georg-Ferdinand Schlingensiepen
Also filed as: SCHLINGENSIEPEN GEORG-F · SCHLINGENSIEPEN GEORG-FERDINAN · SCHLINGENSIEPEN GEORG-FERDINAND
4 granted patents·94 citations·filing 1994–2006
78Inventor score
Top patents by PatentIndex Score
4 records- 0188US7667027B2Antisense-oligonucleotides for the treatment of immuno-suppressive effects of transforming growth factor-β (TGF-β)BIOGNOSTIK GES·Filed 2006·Granted Feb 23, 2010·15 cites·2 claims
- 0284US6455689B1Antisense-oligonucleotides for transforming growth factor-β (TGF-β)BIOGNOSTIK GES·Filed 1994·Granted Sep 24, 2002·49 cites·6 claims
- 0365US6365345B1Antisense nucleic acids for the prevention and treatment of disorders in which expression of c-erbB plays a roleBIOGNOSTIK GESELLSCAHFT FUER B·Filed 1994·Granted Apr 2, 2002·30 cites·5 claims
- 0428US7326783B2Pharmaceutical composition comprising antisense-nucleic acid for prevention and/or treatment of neuronal injury, degeneration and cell death and for the treatment of neoplasmsBIOGNOSTIK GES·Filed 1994·Granted Feb 5, 2008·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Georg-Ferdinand Schlingensiepen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →